查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363100

药品稳定和储存服务北美和欧洲市场规模、份额和趋势分析报告：按服务、分子、模式、地区和细分市场预测，2023-2030 年

North America And Europe Pharmaceutical Stability & Storage Services Market Size, Share & Trends Analysis Report By Services (Stability, Storage), By Molecule (Large Molecule, Small Molecule), By Mode, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 133 Pages | 商品交期: 2-10个工作天内

价格

北美和欧洲药品稳定和储存服务市场成长和趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，北美和欧洲的药品稳定和储存服务市场规模预计将达到 32.2 亿美元。

预计2023年至2030年该市场将以5.5%的年复合成长率成长。严格的法规要求、不断增加的研发投资和临床试验的全球化是推动市场成长的一些关键要素。

生物相似药需求的成长预计将推动市场进步。近年来，生物相似药的核准率显着提高。根据2020年发布的安进生物类似药趋势报告，美国核准的生物类似药数量较上一年增长了65%，截至2023年，美国已核准41种产品，美国已批准70多种产品。欧盟。扩大生物相似药的核准可能会对市场产生积极影响。

药物稳定性在决定药物的强度和有效性方面起着重要作用。然而，确保稳定性受到法规机构不同的资料要求和测试法规的挑战，使得产品在不同地区的销售尤其困难。儘管 EMA 和 FDA 都遵守 ICH 稳定性测试指南，但这些测试具有不同的微生物极限。因此，某些在美国可选的评估可能在欧盟成为强制性的，反之亦然。这些差异使稳定性测试程序变得复杂，并增加了外包此类测试服务的需求。

一些公司正在采取收购、合作和推出新服务等策略来获得市场地位。例如，2023 年 3 月，BioLife Solutions 推出了 Ultraguard-70°C 相变材料 (PCM) 配件，为 ULT 冰箱提供备用冷却，并作为桌面生物製药存放的干冰替代。此外，2022 年 10 月，CSafe 和 BioLife Solutions, Inc. 建立了合作伙伴关係，以增强细胞和基因治疗供应链解决方案。 CSafe 加入 BioLife 的全球合作伙伴网络，为细胞和基因疗法市场提供冷链解决方案。

北美和欧洲药品稳定和储存服务市场报告亮点：

  • 到2022年，稳定领域将主导区域市场，生物製药和个体化药物需求的激增将推动药物稳定性服务的进步。
  • 按服务划分，由于发展中地区对仿製药和生物仿製药的关注度不断提高，储存领域预计在预测期内年复合成长率为 6.1%。
  • 2022 年的市场将由小分子领域主导。预测、基于结构的设计、成像、自动化、人工智慧和机器学习的最新进展是提高小分子先导化合物最佳化的步伐和成功率的关键促进因素。
  • 聚合物领域也在市场上占有重要份额。这是由于越来越多地采用蛋白质、核酸、碳水化合物、生物细胞和组织等大分子。
  • 2022年，自家公司部门占据最大市场占有率。大多数药厂选择在自家公司进行稳定性测试。所有药物和临床试验的所有阶段都需要进行这些测试。
  • 北美市场占据主导地位，2022 年销售份额最大，为 71.51%。这是因为该地区有几家主要市场参与者提供稳定性测试和储存服务。
  • 预计欧洲在未来年度也将占很大比例。英国注重医药领域的研发。随着公司投资开发新药和进行临床试验，对支援这些活动的稳定性测试和储存服务的需求不断增长。

目录

第1章调查方法与范围

第2章执行摘要

第3章药物稳定与储存服务市场变数、趋势与范围

  • 市场体系预测
    • 母市场预测
    • 附随市场预测
  • 药物稳定与储存服务市场
  • 市场动态
    • 市场促进因素影响分析
    • 市场抑制因素分析
    • 产业趋势
    • 机会分析
  • 波特五力分析
  • PESTEL分析
  • COVID-19 对北美和欧洲药品稳定和储存服务市场的影响

第4章北美和欧洲药品稳定和储存服务市场：2018-2030 年按服务分类的細項分析

  • 北美和欧洲药品稳定和储存服务市场：服务变化分析
  • 按服务
  • 稳定的
  • 贮存

第5章北美和欧洲药物稳定和储存服务市场：2018-2030 年分子細項分析

  • 北美和欧洲分子药物稳定和储存服务市场：要点
  • 2022年和2030年分子变异分析和市场占有率
  • 按分子分类
  • 低分子
  • 高分子

第6章北美和欧洲药品稳定和储存服务市场：按模式細項分析，2018-2030

  • 北美和欧洲药品稳定和储存服务市场（按模式）：要点
  • 2022年和2030年模式变化分析和市场占有率
  • 按模式
  • 公司内部
  • 外包

第7章北美和欧洲药物稳定和储存服务市场：按服务、分子和模式进行区域估计和趋势分析

  • 北美和欧洲药品稳定和储存服务市场：区域展望
  • 北美洲
  • 欧洲

第8章竞争形势

  • 热图分析
  • 参与企业概况
  • 财务实绩
  • 服务标竿
  • 策略规划
    • 获得
    • 扩张
    • 伙伴关係与协作
    • 产品发表会
  • 公司市场占有率分析（2022年）
  • 公司名录
Product Code: GVR-4-68040-123-7

North America And Europe Pharmaceutical Stability & Storage Services Market Growth & Trends:

The North America and Europe pharmaceutical stability & storage services market size is expected to reach USD 3.22 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to grow at a CAGR of 5.5% from 2023 to 2030. Stringent regulatory requirements, increasing R&D investments, and globalization of clinical trials are some of the major factors driving market growth.

The rising demand for biosimilars is expected to drive market advancement. In recent years, the approval rate for biosimilars has significantly improved. As per the Amgen Biosimilars Trend Report published in 2020, there was an increase in the number of biosimilar approvals by 65% since the preceding year in the U.S. As of 2023, 41 biosimilars were approved in the U.S., and over 70 were approved in the EU. The growing approval of biosimilars is likely to positively impact the market.

The stability of pharmaceuticals plays a crucial role in determining the strength and effectiveness of the medication. However, ensuring stability poses challenges due to varying data requirements and testing regulations imposed by different regulatory bodies, making it particularly difficult to market products in diverse regions. While both the EMA and FDA adhere to the ICH guidelines for stability testing, they maintain distinct microbiological limits for these tests. Consequently, certain evaluations that are optional in the United States become mandatory in the European Union, and vice versa. These disparities complicate stability testing procedures, leading to an increased need for outsourcing such testing services.

Several companies are involved in strategies such as acquisitions, collaborations, and new service launches to gain positions in the market. For instance, in March 2023, BioLife Solutions introduced the Ultraguard -70°C Phase Change Material (PCM) Accessory to offer backup cooling in ULT Freezers and act as a dry ice substitute for benchtop biologic material storage. Moreover, in October 2022, CSafe and BioLife Solutions, Inc. formed a partnership to enhance supply chain solutions for cell and gene therapy. CSafe joined BioLife's global partner network of companies offering cold chain solutions for the cell and gene therapies market.

North America And Europe Pharmaceutical Stability & Storage Services Market Report Highlights:

  • The stability segment dominated the regional market in 2022. The rapid growth in the demand for biopharmaceuticals and personalized medicines is driving advancements in pharmaceutical stability services
  • Based on service, the storage segment is expected to witness the highest CAGR of 6.1% over the forecast period, owing to the increasing focus on generics and biosimilars in developing regions
  • The small molecules segment dominated the market in 2022. Recent advances in forecasting, structure-based design, imaging, automation, artificial intelligence, and machine learning have become critical facilitators for increasing small molecule lead optimization's pace and success rates
  • The large molecule segment also holds a significant share in the market. This is due to the increasing adoption of large molecules such as proteins, nucleic acids, carbohydrates, living cells, and tissues
  • In 2022, the in-house segment held the largest market share. Most pharmaceutical manufacturers choose in-house stability testing, as these tests are required to be performed for all drugs and in all phases of clinical studies
  • North America dominated the market, accounting for the largest revenue share of 71.51% in 2022, due to the presence of several major market players providing stability and storage services in the region
  • Europe is also expected to account for a significant share of the market in the coming years. The UK has a strong emphasis on R&D in the pharmaceutical sector. As companies invest in developing new drugs and conducting clinical trials, there is an increased demand for stability testing and storage services to support these activities

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
  • 1.2 Market Definitions
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Information analysis
    • 1.4.2 Market formulation & data visualization
    • 1.4.3 Data validation & publishing
  • 1.5 Research Scope and Assumptions
    • 1.5.1 Approach 1: Commodity Flow Analysis
    • 1.5.2 Approach 2: Hybrid Model Analysis
    • 1.5.3 Hybrid Model market estimation
    • 1.5.4 Region/Country-based segment share calculation
    • 1.5.5 Multivariate analysis
    • 1.5.6 CAGR Calculation
  • 1.6 List of Secondary Sources
  • 1.7 Objectives
    • 1.7.1 Objective - 1
    • 1.7.2 Objective - 2
    • 1.7.3 Objective - 3
    • 1.7.4 Objective - 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Segment Snapshot
  • 2.4 Competitive Landscape Snapshot

Chapter 3 Pharmaceutical Stability & Storage Services Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Pharmaceutical Stability & Storage Services Market
  • 3.3 Market Dynamics
    • 3.3.1 Market driver impact analysis
      • 3.3.1.1 High R&D spending of pharmaceutical & biotechnology companies
      • 3.3.1.2 Growing demand for outsourcing stability testing due to the high complexity associated with drug stability
      • 3.3.1.3 Growing demand for biosimilars
    • 3.3.2 Market restraint analysis
      • 3.3.2.1 Stringent regulations for Pharmaceutical Stability and Storage Services of drugs
      • 3.3.2.2 Issues Associated with stability chambers
    • 3.3.3 Industry Trends
      • 3.3.3.1 Expansion of cold chain logistics
    • 3.3.4 Opportunity Analysis
      • 3.3.4.1 Increasing demand for personalized medicine
  • 3.4 Porter's Five Forces Analysis
  • 3.5 PESTEL Analysis
  • 3.6 Impact of COVID-19 on North America and Europe Pharmaceutical Stability & Storage Services Market

Chapter 4 North America and Europe Pharmaceutical Stability & Storage Services Market: Segment Analysis, by Services, 2018 - 2030 (USD Million)

  • 4.1 North America and Europe Pharmaceutical Stability & Storage Services Market: Services Movement Analysis
  • 4.2 North America and Europe Pharmaceutical Stability & Storage Services Market Estimates & Forecast, By Services (USD Million)
    • 4.2.1 North America and Europe Pharmaceutical Stability & Storage Services Market Estimates & Forecast, By Stability Type (USD Million)
    • 4.2.2 North America and Europe Pharmaceutical Stability & Storage Services Market Estimates & Forecast, By Storage Type (USD Million)
  • 4.3 Stability
    • 4.3.1 Drug Substance
    • 4.3.2 Stability indicating method validation
    • 4.3.3 Accelerated stability testing
    • 4.3.4 Photostability Testing
    • 4.3.5 Other stability testing methods
  • 4.4 Storage
    • 4.4.1 Cold
    • 4.4.2 Non-cold

Chapter 5 North America and Europe Pharmaceutical Stability & Storage Services Market: Segment Analysis, by Molecule, 2018 - 2030 (USD Million)

  • 5.1 North America and Europe Pharmaceutical Stability & Storage Services Market by Molecule: Key Takeaways
  • 5.2 Molecule Movement Analysis & Market Share, 2022 & 2030
  • 5.3 North America and Europe Pharmaceutical Stability & Storage Services Market Estimates & Forecast, By Molecule (USD Million)
    • 5.3.1 North America and Europe Pharmaceutical Stability & Storage Services Market Estimates & Forecast, By Small Molecules (USD Million)
    • 5.3.2 North America and Europe Pharmaceutical Stability & Storage Services Market Estimates & Forecast, By Large Molecules (USD Million)
  • 5.4 Small Molecule
    • 5.4.1 Small Molecule market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2 Research Products
      • 5.4.2.1 Research Products market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3 Commercial Products
      • 5.4.3.1 Commercial Products market estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5 Large Molecule
    • 5.5.1 Large Molecule market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2 Research Products
      • 5.5.2.1 Research Products market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3 Commercial Products
      • 5.5.3.1 Commercial Products market estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6 North America and Europe Pharmaceutical Stability & Storage Services Market: Segment Analysis, by Mode, 2018 - 2030 (USD Million)

  • 6.1 North America and Europe Pharmaceutical Stability & Storage Services Market by Mode: Key Takeaways
  • 6.2 Mode Movement Analysis & Market Share, 2022 & 2030
  • 6.3 North America and Europe Pharmaceutical Stability & Storage Services Market Estimates & Forecast, By Mode (USD Million)
  • 6.4 In-House
    • 6.4.1 In-House market estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5 Outsourcing
    • 6.5.1 Outsourcing market estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7 North America and Europe Pharmaceutical Stability & Storage Services Market: Regional Estimates and Trend Analysis, by Services, by Molecule, by Mode.

  • 7.1 North America and Europe Pharmaceutical Stability & Storage Services Market: Regional Outlook
  • 7.2 North America
      • 7.2.1.1 North America Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 Key Country Dynamics
      • 7.2.2.2 Competitive Scenario
      • 7.2.2.3 Regulatory Framework
      • 7.2.2.4 U.S. Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Key Country Dynamics
      • 7.2.3.2 Competitive Scenario
      • 7.2.3.3 Regulatory Framework
      • 7.2.3.2 Canada Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3 Europe
      • 7.3.1.1 Europe Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2 UK
      • 7.3.2.1 Key Country Dynamics
      • 7.3.2.2 Competitive Scenario
      • 7.3.2.3 Regulatory Framework
      • 7.3.2.4 UK Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3 Germany
      • 7.3.3.1 Key Country Dynamics
      • 7.3.3.2 Competitive Scenario
      • 7.3.3.3 Regulatory Framework
      • 7.3.3.4 Germany Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 Key Country Dynamics
      • 7.3.4.2 Competitive Scenario
      • 7.3.4.3 Regulatory Framework
      • 7.3.4.4 France Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5 Italy
      • 7.3.5.1 Key Country Dynamics
      • 7.3.5.2 Competitive Scenario
      • 7.3.5.3 Regulatory Framework
      • 7.3.5.4 Italy Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million
    • 7.3.6 Spain
      • 7.3.6.1 Key Country Dynamics
      • 7.3.6.2 Competitive Scenario
      • 7.3.6.3 Regulatory Framework
      • 7.3.6.4 Spain Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million
    • 7.3.7 Denmark
      • 7.3.7.1 Key Country Dynamics
      • 7.3.7.2 Competitive Scenario
      • 7.3.7.3 Regulatory Framework
      • 7.3.7.4 Denmark Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million
    • 7.3.8 Sweden
      • 7.3.8.1 Key Country Dynamics
      • 7.3.8.2 Competitive Scenario
      • 7.3.8.3 Regulatory Framework
      • 7.3.8.4 Sweden Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million
    • 7.3.9 Norway
      • 7.3.9.1 Key Country Dynamics
      • 7.3.9.2 Competitive Scenario
      • 7.3.9.3 Regulatory Framework
      • 7.3.9.4 Norway Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million

Chapter 8 Competitive Landscape

  • 8.1 Heat Map Analysis
  • 8.2 Participants Overview
  • 8.3 Financial Performance
  • 8.4 Service Benchmarking
  • 8.5 Strategy Mapping
    • 8.5.1 Acquisition
    • 8.5.2 Expansion
    • 8.5.3 Partnership & Collaboration
    • 8.5.4 Product Launch
  • 8.6 Company Market Share Analysis (2022)
  • 8.7 List of Players

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. North America and Europe Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 4. North America and Europe Pharmaceutical Stability & Storage Services Market by Molecule, 2018 - 2030 (USD Million)
  • Table 5. North America and Europe Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 6. North America and Europe Pharmaceutical Stability & Storage Services Market by Region, 2018 - 2030 (USD Million)
  • Table 7. North America Pharmaceutical Stability & Storage Services Market by Country, 2018 - 2030 (USD Million)
  • Table 8. North America Pharmaceutical Stability & Storage Services Market by Service, 2018 - 2030 (USD Million)
  • Table 9. North America Pharmaceutical Stability & Storage Services Market by Molecule, 2018-2030 (USD Million)
  • Table 10. North America Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 11. U.S. Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 12. U.S. Pharmaceutical Stability & Storage Services Market by Molecule, 2018 - 2030 (USD Million)
  • Table 13. U.S. Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 14. Canada Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 15. Canada Pharmaceutical Stability & Storage Services Market by Molecule, 2018 - 2030 (USD Million)
  • Table 16. Canada Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 17. Europe Pharmaceutical Stability & Storage Services Market by Country, 2018 - 2030 (USD Million)
  • Table 18. Europe Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 19. Europe Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 20. Europe Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 21. Germany Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 22. Germany Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 23. Germany Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 24. UK Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 25. UK Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 26. UK Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 27. France Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 28. France Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 29. France Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 30. Italy Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 31. Italy Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 32. Italy Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 33. Spain Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 34. Spain Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 35. Spain Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 36. Denmark Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 37. Denmark Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 38. Denmark Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 39. Sweden Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 40. Sweden Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 41. Sweden Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 42. Norway Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 43. Norway Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 44. Norway Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Pharmaceutical Stability & Storage Services Market: Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 10 Penetration & Growth Prospect Mapping
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Market Penetration vs. Growth Prospect Mapping, 2021
  • Fig. 14 Regional Marketplace: Key Takeaways
  • Fig. 15 North America and Europe Pharmaceutical Stability & Storage Services Market for Stability, 2018 - 2030 (USD Million)
  • Fig. 16 North America and Europe Pharmaceutical Stability & Storage Services Market for Drug Substance, 2018 - 2030 (USD Million)
  • Fig. 17 North America and Europe Pharmaceutical Stability & Storage Services Market for Stability indicating method validation , 2018 - 2030 (USD Million)
  • Fig. 18 North America and Europe Pharmaceutical Stability & Storage Services Market for Accelerated stability testing , 2018 - 2030 (USD Million)
  • Fig. 19 North America and Europe Pharmaceutical Stability & Storage Services Market for Photostability Testing , 2018 - 2030 (USD Million)
  • Fig. 20 North America and Europe Pharmaceutical Stability & Storage Services Market for Other stability testing methods, 2018 - 2030 (USD Million)
  • Fig. 21 North America and Europe Pharmaceutical Stability & Storage Services Market for Storage, 2018 - 2030 (USD Million)
  • Fig. 22 North America and Europe Pharmaceutical Stability & Storage Services Market for Cold storage, 2018 - 2030 (USD Million)
  • Fig. 23 North America and Europe Pharmaceutical Stability & Storage Services Market for Non-cold storage, 2018 - 2030 (USD Million)
  • Fig. 24 North America and Europe Pharmaceutical Stability & Storage Services Market for Small Molecule, 2018 - 2030 (USD Million)
  • Fig. 25 North America and Europe Pharmaceutical Stability & Storage Services Market for Research Products, 2018 - 2030 (USD Million)
  • Fig. 26 North America and Europe Pharmaceutical Stability & Storage Services Market for Commercial Products, 2018 - 2030 (USD Million)
  • Fig. 27 North America and Europe Pharmaceutical Stability & Storage Services Market for Large Molecule, 2018 - 2030 (USD Million)
  • Fig. 28 North America and Europe Pharmaceutical Stability & Storage Services Market for Research Products, 2018 - 2030 (USD Million)
  • Fig. 29 North America and Europe Pharmaceutical Stability & Storage Services Market for Commercial Products, 2018 - 2030 (USD Million)
  • Fig. 30 North America and Europe Pharmaceutical Stability & Storage Services Market for In-house services, 2018 - 2030 (USD Million)
  • Fig. 31 North America and Europe Pharmaceutical Stability & Storage Services Market for Outsourcing services, 2018 - 2030 (USD Million)
  • Fig. 32 Regional Outlook, 2021 & 2030
  • Fig. 33 North America Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 38 UK Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 39 France Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 41 Spain Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 44 Norway Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)